Literature DB >> 20395568

Ethical imperative of posttrial access to antiretroviral treatment.

Onyekachi Sunny Onyeabor.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20395568      PMCID： PMC2866584          DOI： 10.2105/AJPH.2009.186288

Source DB:  PubMed          Journal:  Am J Public Health        ISSN： 0090-0036            Impact factor:   9.308


× No keyword cloud information.
  4 in total

1.  Equitable treatment for HIV/AIDS clinical trial participants: a focus group study of patients, clinician researchers, and administrators in Western Kenya.

Authors:  D N Shaffer; V N Yebei; J B Ballidawa; J E Sidle; J Y Greene; E M Meslin; S J N Kimaiyo; W M Tierney
Journal:  J Med Ethics       Date:  2006-01       Impact factor: 2.903

Review 2.  Barriers to access to antiretroviral treatment in developing countries: a review.

Authors:  Mariana Posse; Filip Meheus; Henri van Asten; Andre van der Ven; Rob Baltussen
Journal:  Trop Med Int Health       Date:  2008-05-06       Impact factor: 2.622

Review 3.  Planning for posttrial access to antiretroviral treatment for research participants in developing countries.

Authors:  Seema Shah; Stacey Elmer; Christine Grady
Journal:  Am J Public Health       Date:  2009-07-16       Impact factor: 9.308

4.  Community perspectives on care options for HIV prevention trial participants.

Authors:  K M MacQueen; E Namey; D A Chilongozi; S P Mtweve; M Mlingo; N Morar; C Reid; A Ristow; S Sahay
Journal:  AIDS Care       Date:  2007-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.